Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Vulvodynia is a heterogenous gynaecological condition that can have a significant impact on the physical and psychological well-being of affected women. It should be considered within the differential diagnosis in a number of gynaecological presentations, including superficial dyspareunia, apparent persistent/recurrent candidiasis and chronic vulval symptoms such as discomfort and itch. Although vulvodynia is widely considered to be an idiopathic pain syndrome, there is a growing body of research into a complex array of factors thought to play a role in its pathogenesis. There is no ‘one-size-fits-all’ approach to treatment; successful management often relies upon a multimodal and multidisciplinary approach. Despite its high prevalence, vulvodynia remains a poorly recognized condition and women often experience barriers in accessing diagnosis and treatment. Promoting increased awareness of vulvodynia among clinicians and the wider public is therefore an important endeavour.

Original publication

DOI

10.1016/j.mpmed.2022.02.003

Type

Journal article

Journal

Medicine (United Kingdom)

Publication Date

01/05/2022

Volume

50

Pages

290 - 293